See also this year's filing and all EDGAR filings for this company.
PDF Report 0001472012_2024_Immunome_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations - Calc2': 2, '00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 9}} |
Graph
Absolute values for 0001472012, Immunome Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 144,703,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,073,000 |
| 3 | remainder_Assets | 1,764,000 |
| 4 | LiabilitiesCurrent | 21,829,000 |
| 5 | LiabilitiesNoncurrent | 6,829,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 41,120,203 |
| 9 | ResearchAndDevelopmentExpense | 22,843,915 |
| 10 | remainder_Expenses | 53,015,826 |
| 11 | remainder_Revenues | 14,018,000 |
| 12 | remainder_NetIncome | 10,217 |
| 13 | remainder_ComprehensiveNetIncome | 201 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 148,540,000 |
| 1 | Liabilities | 28,658,000 |
| 2 | Expenses | 116,979,944 |
| 3 | Revenues | 14,018,000 |
| 4 | StockholdersEquity | 119,882,000 |
| 5 | NetIncome | -102,951,727 |
| 6 | ComprehensiveNetIncome | -102,951,626 |
| 7 | BaseVar | 154,103,181 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.79 |
| 9 | EconomicCapitalRatio | 2.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
